Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/30/2025

Diagnostic Approach to Copper-Related Neurological Disorders

Introduction to Ceruloplasmin and Serum Copper

  • The American Association for the Study of Liver Diseases recommends that serum ceruloplasmin should be routinely measured during evaluation of unexplained neurologic symptoms, as ceruloplasmin is the primary carrier for copper in blood, accounting for 90% of circulating copper in normal individuals 1, 2, 3
  • Ceruloplasmin is the recommended first-line test when evaluating unexplained neurologic abnormalities in children and adults through middle age, with low ceruloplasmin (<200 mg/L or <20 mg/dL) being consistent with Wilson disease, and extremely low levels (<50 mg/L or <5 mg/dL) providing strong diagnostic evidence 1, 2, 3, 4

Diagnostic Value of Ceruloplasmin and Serum Copper

  • Total serum copper is usually decreased in Wilson disease (proportional to decreased ceruloplasmin), making it paradoxically low in a disease of copper overload, and serum copper measurement alone cannot distinguish between copper bound to ceruloplasmin (non-toxic) and free copper (toxic) 1, 2, 3
  • The diagnostic value comes from calculating non-ceruloplasmin-bound copper, which requires both serum copper AND ceruloplasmin measurements, with the American Association for the Study of Liver Diseases specifically recommending ceruloplasmin as the primary screening test 1, 2, 3

Practical Testing Approach

  • Order ceruloplasmin as the primary screening test, and if ceruloplasmin is low or borderline, then add serum copper to calculate free (non-ceruloplasmin-bound) copper, with consideration of 24-hour urinary copper excretion if ceruloplasmin is abnormal (normal <40 μg/24 hours; Wilson disease typically >100 μg/24 hours) 1, 2, 3, 5
  • Extremely low ceruloplasmin (<50 mg/L) is strong evidence for Wilson disease, while modestly subnormal ceruloplasmin (50-200 mg/L) requires further evaluation with urinary copper and possibly genetic testing, and normal ceruloplasmin does NOT exclude Wilson disease, as 10-20% of patients have normal levels 1, 2

Critical Caveats

  • Approximately 20% of heterozygotes for Wilson disease have decreased ceruloplasmin but do not have the disease, and ceruloplasmin is an acute phase reactant and may be falsely elevated during inflammation or infection, potentially masking Wilson disease 1, 3, 4
  • Enzymatic assays measuring oxidase activity are preferred over immunologic assays, as immunologic methods may overestimate functional ceruloplasmin, and copper deficiency (which also causes low ceruloplasmin) can occur at any age and should be considered in the differential 3

Diagnostic Evaluation of Copper Disorders

Plasma/Serum Copper Measurement

  • Plasma or serum copper should be quantified with inductively coupled plasma mass spectrometry (ICP‑MS) or atomic absorption spectroscopy to ensure accurate results. 6

Free (Non‑Ceruloplasmin‑Bound) Copper

  • Approximately 10 % of total plasma copper exists as non‑ceruloplasmin‑bound (free) copper, the metabolically active fraction. 7, 8
  • Free copper is calculated using the formula: Free copper (μg/L) = Total serum copper (μg/L) – (3.15 × ceruloplasmin in mg/L). 7
  • A free‑copper concentration > 25 μg/dL (250 μg/L) supports a diagnosis of Wilson disease, whereas a value < 5 μg/dL together with low urinary copper indicates copper deficiency. 7, 8

Total Plasma/Serum Copper in Wilson Disease

  • In Wilson disease, total plasma copper is paradoxically decreased because ceruloplasmin levels are low. 7
  • During acute liver failure caused by Wilson disease, plasma copper may become markedly elevated due to rapid release from hepatic stores. 7

Urinary Copper Excretion

  • A 24‑hour urinary copper excretion > 100 μg/24 h is typical for Wilson disease. 7

Whole‑Blood Copper Measurement

  • Whole‑blood copper (the sum of plasma and RBC copper) offers limited clinical utility and is not recommended for diagnosing Wilson disease or copper deficiency. 6

Summary of Copper Measurements

Measurement What It Reflects Clinical Utility Key References
Plasma/Serum Copper Total circulating copper (ceruloplasmin‑bound + free) Standard test; basis for free‑copper calculation [7], [6]
Free (Non‑Ceruloplasmin) Copper Metabolically active, potentially toxic copper Elevated in Wilson disease (>25 μg/dL); low in deficiency [7], [8]
Whole‑Blood Copper Combined plasma + RBC copper Limited diagnostic value; not recommended [6]

All facts are derived from peer‑reviewed sources cited above; no strength of evidence grading was provided in the source material.